FundedIQ
Biotechnology

AlgiKnit: Funding, Investors & Team (Sep 2026)

AlgiKnit is a biomaterials organization incorporating science and plan into material creation. The organization imagines a future where the material business works in a shut circle item lifecycle, using materials with an essentially lower impression than customary materials.

algiknit.com LinkedIn Brooklyn, United States 11-50 employees
Biotechnology Product Design Sustainability Textiles
Total raised
$15.4M
Rounds
2
Latest
Series A
Jun 2022

AlgiKnit has raised $15.4M across 2 funding rounds on record, the most recent a Series A of $13.0M announced in Jun 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

AlgiKnit Company Profile and Key Stats

Total funding raised
$15.4M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series A
$13.0M in Jun 2022
Employees
11-50
reported band
Headquarters
Brooklyn, United States

Latest funding round on record: Jun 2022.

AlgiKnit Funding Rounds

Date
Round
Amount
Series A
$13.0M
Undisclosed round
$2.4M

AlgiKnit raised $2.4M in an undisclosed round announced in Mar 2021.

1.3 years later, a Series A of $13.0M was announced in Jun 2022.

AlgiKnit Founders and Leadership Team

Name
Role
Contact
Aaron Nesser
Founder
Locked

Contact details for the AlgiKnit team: 1 of 1 has an email address on file.

Start 14-day free trial →

AlgiKnit Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M
8,422
$15M

AlgiKnit's latest round of $13.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like AlgiKnit in Biotechnology and Brooklyn

Companies Similar to AlgiKnit

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

AlgiKnit Funding FAQs

What does AlgiKnit do?

AlgiKnit is a biomaterials organization incorporating science and plan into material creation. The organization imagines a future where the material business works in a shut circle item lifecycle, using materials with an essentially lower impression than customary materials.

How much funding has AlgiKnit raised?

AlgiKnit has raised $15.4M across 2 rounds on record. The most recent is a Series A of $13.0M announced in Jun 2022.

When did AlgiKnit last raise funding?

AlgiKnit's most recent funding round on record is a Series A of $13.0M, announced in Jun 2022.

Who founded AlgiKnit?

FundedIQ lists Aaron Nesser (Founder) at AlgiKnit.

Where is AlgiKnit headquartered?

AlgiKnit is based in Brooklyn, New York, United States.

How many employees does AlgiKnit have?

AlgiKnit is in the 11-50 employee band.

How does AlgiKnit's funding compare to other Biotechnology startups?

AlgiKnit's latest round of $13.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's AlgiKnit Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AlgiKnit is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.